Bifodobacterium were identified as being critical to antitumor immunity and could mediate therapeutic effects by enhancing host antitumor T cell responses including peripheral T cell induction, CD 8+ T cell infiltration into tumor and dendritic cell activation, which led to enhanced CD8+ T cell priming. The gene discussed is CD8A; the disease is neoplasm.